Search Details

Word: panels (lookup in dictionary) (lookup stats)
Dates: during 1970-1979
Sort By: most recent first (reverse)


Usage:

Whitlock rejected the Lobby's plan in favour of an alternate proposal by the Committee of House and Undergraduate Life. The CHUL plan called for each House to elect two students to a College-wide panel of electors. This panel will then choose two of its members for the ACSR...

Author: By Steven M. Luxenbero, | Title: A Palatable Solution for the ACSR | 12/9/1972 | See Source »

...panel discussion with women in the three fields will close the conference late this afternoon...

Author: NO WRITER ATTRIBUTED | Title: Workshop at Hilles Discusses Careers For Black Women | 12/9/1972 | See Source »

...ELECTIONS WERE HELD early last month and with 1300 students voting, the Union unexpectedly swept to victory. The graduate student voters chose 60 people to a panel--40 of the victors were Union members. The panel selected six graduate students to sit on each of the committees--all of them Union members. The 12 students pledged to work together or the two groups and seek to advance the Union's interests...

Author: By Dan Swanson, | Title: Union Bests Dunlop | 12/8/1972 | See Source »

...Thanksgiving Day the story of Dean Ebert's Mysteclin-F testimony and the history of his relationship with Squibb broke into the press. Morton Mintz of the Washington Post described the hearings in detail. Mintz reported that the FDA panel turned down Ebert's labelling proposal in executive session. "I don't think they showed efficacy," one scientist said, expressing the unanimous sentiment on the panel against the drug. "The deans' data were marginal at best," said another panel member...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

...dean has been paid and sponsored by the very pharmaceutical company whose product he is defending. And if the apparent consensus of medical judgement on Mysteclin-F can be trusted, then Ebert's testimony before the FDA failed to damage the interests of medical consumers only because the advisory panel was wise enough to dismiss his arguments...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

Previous | 169 | 170 | 171 | 172 | 173 | 174 | 175 | 176 | 177 | 178 | 179 | 180 | 181 | 182 | 183 | 184 | 185 | 186 | 187 | 188 | 189 | Next